| 08:30 - 10:30 | 207 | ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session | Grand round |
| 08:30 - 10:30 | 208 | The non-parmacological management of COPD exacerbations | Symposium |
| 08:30 - 10:30 | 209 | ERS/ESCMID Guidelines: Management of lower respiratory tract infections: scores, biomarkers and beyond | Symposium |
| 08:30 - 10:30 | 211 | End-stage lung disease in children | Symposium |
| 08:30 - 10:30 | 212 | The unfolding story of endoplasmic reticulum stress signalling in lung disease | Symposium |
| 08:30 - 10:30 | 213 | Understanding the burden of chronic respiratory diseases: what decision makers need to know | Oral Presentation |
| 08:30 - 10:30 | 214 | Mechanisms of acute lung injury and mesenchymal cell treatment | Oral Presentation |
| 08:30 - 10:30 | 215 | Clinical application of exhaled biomarkers | Oral Presentation |
| 08:30 - 10:30 | 216 | Molecular pathology and functional genomics of lung disease | Oral Presentation |
| 08:30 - 10:30 | 217 | Cardio-pulmonary interactions | Oral Presentation |
| 08:30 - 10:30 | 218 | Viral respiratory infections in children: causes and consequences | Oral Presentation |
| 08:30 - 10:30 | 219 | Indoor hazards and respiratory disease: irritants and allergens | Oral Presentation |
| 08:30 - 10:30 | 220 | Genes, environment and obstruction | Oral Presentation |
| 08:30 - 10:30 | 221 | Obstructive sleep apnoea: the heart and the brain | Poster Discussion |
| 08:30 - 10:30 | 222 | Comorbidities and impact on society of asthma and COPD | Poster Discussion |
| 08:30 - 10:30 | 223 | Models of disease and drug actions | Poster Discussion |
| 08:30 - 10:30 | 224 | Smoking-related diseases and smoking cessation | Poster Discussion |
| 08:30 - 10:30 | 225 | Tuberculosis: from bench to bedside | Poster Discussion |
| 08:30 - 10:30 | 226 | T-cell subsets | Poster Discussion |
| 10:45 - 12:45 | 228 | Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Science Year in Review | Session |
| 10:45 - 12:45 | 229 | The prognostic value of cardiopulmonary exercise testing | Symposium |
| 10:45 - 12:45 | 230 | The digital highway: innovative monitoring of asthma | Symposium |
| 10:45 - 12:45 | 231 | The value of patients as partners in research | Hot topics |
| 10:45 - 12:45 | 232 | Epidemiology of COPD exacerbations | Symposium |
| 10:45 - 12:45 | 233 | Vasculitis and the lung | Symposium |
| 10:45 - 12:45 | 234 | Phenotyping asthma: a clue for treatments? | Oral Presentation |
| 10:45 - 12:45 | 235 | Imaging in COPD | Oral Presentation |
| 10:45 - 12:45 | 236 | The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition) | Oral Presentation |
| 10:45 - 12:45 | 237 | What is new in tuberculosis immunodiagnosis? | Oral Presentation |
| 10:45 - 12:45 | 238 | The burden of work-related respiratory disease: known and new end-points | Oral Presentation |
| 10:45 - 12:45 | 239 | Surgery for lung cancer: pre-operative evaluation and results | Oral Presentation |
| 10:45 - 12:45 | 240 | Resuscitation and ventilation in the baby and infant | Oral Presentation |
| 10:45 - 12:45 | 241 | Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis | Oral Presentation |
| 10:45 - 12:45 | 242 | Tuberculosis in immunocompromised hosts | Poster Discussion |
| 10:45 - 12:45 | 243 | Lung cancer: molecular pathology and functional genomics | Poster Discussion |
| 10:45 - 12:45 | 244 | Progress in endoscopy for the diagnosis of lung cancer | Poster Discussion |
| 10:45 - 12:45 | 245 | Mechanical ventilation and lung injury: new advances | Poster Discussion |
| 10:45 - 12:45 | 246 | Genetic and molecular background in pulmonary fibrosis | Poster Discussion |
| 10:45 - 12:45 | 247 | Advances in lung function testing from infancy to adulthood | Poster Discussion |
| 12:50 - 14:40 | 248 | Acute respiratory failure | Thematic Poster Session |
| 12:50 - 14:40 | 249 | Intensive care outcome | Thematic Poster Session |
| 12:50 - 14:40 | 250 | Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations | Thematic Poster Session |
| 12:50 - 14:40 | 251 | New evidence in home mechanical ventilation | Thematic Poster Session |
| 12:50 - 14:40 | 252 | Respiratory and skeletal muscle assessment in health and disease | Thematic Poster Session |
| 12:50 - 14:40 | 253 | Lung and airway function | Thematic Poster Session |
| 12:50 - 14:40 | 254 | Clinical physiology for clinical problems | Thematic Poster Session |
| 12:50 - 14:40 | 255 | Innovative methods in exercise testing | Thematic Poster Session |
| 12:50 - 14:40 | 256 | Epidemiology, diagnosis and treatment in obstructive sleep apnoea | Thematic Poster Session |
| 12:50 - 14:40 | 257 | Physiology and diagnostic technology in obstructive sleep apnoea | Thematic Poster Session |
| 12:50 - 14:40 | 258 | Cardiometabolic and neurocognitive changes in obstructive sleep apnoea | Thematic Poster Session |
| 12:50 - 14:40 | 259 | Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities | Thematic Poster Session |
| 12:50 - 14:40 | 260 | Obstructive sleep apnoea: clinical aspects I | Thematic Poster Session |
| 12:50 - 14:40 | 261 | Treatment of human pulmonary hypertension | Thematic Poster Session |
| 12:50 - 14:40 | 262 | Physiology of human pulmonary hypertension | Thematic Poster Session |
| 12:50 - 14:40 | 263 | Clinical features of pulmonary hypertension | Thematic Poster Session |
| 12:50 - 14:40 | 264 | Clinical features of pulmonary thromboembolism | Thematic Poster Session |
| 12:50 - 14:40 | 265 | Pulmonary hypertension in hypoxic lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 266 | Treatment of pulmonary hypertension | Thematic Poster Session |
| 12:50 - 14:40 | 267 | Chest wall trauma and airway management | Thematic Poster Session |
| 12:50 - 14:40 | 268 | General thoracic surgery I | Thematic Poster Session |
| 12:50 - 14:40 | 269 | Lung transplantation | Thematic Poster Session |
| 12:50 - 14:40 | 270 | Aetiology, diagnosis and outcomes in community-acquired pneumonia | Thematic Poster Session |
| 12:50 - 14:40 | 271 | Assessment of severity and predictors of outcomes in community-acquired pneumonia | Thematic Poster Session |
| 12:50 - 14:40 | 272 | New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections | Thematic Poster Session |
| 12:50 - 14:40 | 273 | Infection in the immunocompromised host: infrequent aetiologies | Thematic Poster Session |
| 12:50 - 14:40 | 274 | Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis | Thematic Poster Session |
| 12:50 - 14:40 | 275 | Antimicrobial treatment and resistance in lower respiratory tract infections | Thematic Poster Session |
| 12:50 - 14:40 | 276 | Clinical tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 277 | Management of tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 278 | Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 279 | Tuberculosis epidemiology and public health | Thematic Poster Session |
| 12:50 - 14:40 | 280 | Risk assessment for tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 281 | Extrapulmonary tuberculosis and surgical interventions | Thematic Poster Session |
| 12:50 - 14:40 | 282 | Pulmonary and extrapulmonary tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 283 | Clinical challenges in tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 284 | Epidemiology of lung cancer and screening | Thematic Poster Session |
| 12:50 - 14:40 | 285 | Imaging, functional evaluation and staging for lung cancer patients | Thematic Poster Session |
| 12:50 - 14:40 | 286 | Palliation and morbidity in lung cancer patients | Thematic Poster Session |
| 12:50 - 14:40 | 287 | Biomarkers and other new methods for lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 288 | Instructive clinical aspects of lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 289 | Pleural and mediastinal malignancies: management and rare clinical cases | Thematic Poster Session |
| 12:50 - 14:40 | 290 | Medical education | Thematic Poster Session |
| 13:00 - 14:30 | 291 | ERS/NEJM Late breaking research session | Symposium |
| 13:00 - 14:15 | 292 | ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project) | Symposium |
| 13:00 - 14:15 | 293 | How to integrate care: crossing European borders | Symposium |
| 14:45 - 16:45 | 314 | Romain Pauwels Research Award Ceremony (supported by GlaxoSmithKline) followed by Imaging of the lung parenchyma: an interactive session on interpretation strategies | Grand round |
| 14:45 - 16:45 | 315 | Paediatric Year in Review | Session |
| 14:45 - 16:45 | 316 | Highlights in the treatment of pleural empyema | Symposium |
| 14:45 - 16:45 | 317 | Cancer tissue is the issue | Symposium |
| 14:45 - 16:45 | 318 | Innate immune responses in COPD and severe asthma: new targets for therapy? | Symposium |
| 14:45 - 16:45 | 319 | Bone marrow-derived stem cells in respiratory diseases: a future therapy? | Hot topics |
| 14:45 - 16:45 | 320 | COPD: mechanisms and biomarker | Oral Presentation |
| 14:45 - 16:45 | 321 | Barrier functions in sepsis and acute lung injury | Oral Presentation |
| 14:45 - 16:45 | 322 | Treatment options and tumour biology of malignant pleural mesothelioma | Oral Presentation |
| 14:45 - 16:45 | 323 | COPD: burden of disease, imaging and management | Oral Presentation |
| 14:45 - 16:45 | 324 | Comorbidities and management in primary care | Oral Presentation |
| 14:45 - 16:45 | 325 | Noninvasive ventilation on the intensive care unit: from novel application to end of life issues | Oral Presentation |
| 14:45 - 16:45 | 326 | Chest physiotherapy and breathing retraining | Oral Presentation |
| 14:45 - 16:45 | 327 | Novel clinical features of acute and chronic lung diseases | Oral Presentation |
| 14:45 - 16:45 | 328 | Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation | Poster Discussion |
| 14:45 - 16:45 | 329 | Role of infection in exacerbations of COPD | Poster Discussion |
| 14:45 - 16:45 | 330 | Quality control in lung function and exercise-related issues | Poster Discussion |
| 14:45 - 16:45 | 331 | Obstructive sleep apnoea: inflammation and metabolism | Poster Discussion |
| 14:45 - 16:45 | 332 | Improving outcomes after lung transplantation | Poster Discussion |
| 14:45 - 16:45 | 333 | Epithelial cell biology | Poster Discussion |